Crossmark

Comprehensive Analysis of FDA Form 483 Issued for Biologics from 2010 to 2025: Identifying Trends and Areas of Concern

Published Online: 2026-01-12

Published Print: 2026-04

Authors

Radhakrishnan, Prarthana

S.P, Dhanabal

GNK, Ganesh
License Information

Text and Data Mining valid from 2026-01-12

Version of Record valid from 2026-01-12
More Information

Article History

Received: 11 September 2025

Accepted: 24 December 2025

First Online: 12 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current